Advertisement
UK markets close in 30 minutes
  • FTSE 100

    7,875.21
    +27.22 (+0.35%)
     
  • FTSE 250

    19,401.97
    +61.83 (+0.32%)
     
  • AIM

    744.94
    +1.82 (+0.24%)
     
  • GBP/EUR

    1.1679
    +0.0012 (+0.10%)
     
  • GBP/USD

    1.2445
    -0.0011 (-0.09%)
     
  • Bitcoin GBP

    51,176.63
    +1,973.30 (+4.01%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,050.22
    +28.01 (+0.56%)
     
  • DOW

    38,047.76
    +294.45 (+0.78%)
     
  • CRUDE OIL

    82.41
    -0.28 (-0.34%)
     
  • GOLD FUTURES

    2,390.10
    +1.70 (+0.07%)
     
  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     
  • HANG SENG

    16,385.87
    +134.03 (+0.82%)
     
  • DAX

    17,835.46
    +65.44 (+0.37%)
     
  • CAC 40

    8,027.35
    +45.84 (+0.57%)
     

Caterpillar, Avon Products, JA Solar Holdings, Mesoblast and 21Vianet Group highlighted as Zacks Bull and Bear of the Day

Tilly's (TLYS) closed the most recent trading day at $16.18, moving -0.98% from the previous trading session.

For Immediate Release

Chicago, IL – Nov 16, 2017 – Zacks Equity Research highlights Caterpillar CAT as the Bull of the Day and Avon Products AVP as the Bear of the Day. In addition, Zacks Equity Research provides analysis on the JA Solar Holdings Co., Ltd. JASO, Mesoblast Limited MESO and 21Vianet Group, Inc. VNET.

Here is a synopsis of all five stocks:

Bull of the Day:

Headquartered in Deerfield, IL, Caterpillar is the world's largest heavy-machinery maker and seen as a bellwether for global economic activity.

The company has benefitted a lot from improving global growth and a weak dollar since it derives more than half its sales from international markets.

ADVERTISEMENT

Impressive Results

Caterpillar reported another strong quarter with adjusted earnings per share surging 129% year over year. Earnings also beat the Zacks Consensus Estimate of $1.22 by 60%. Revenues improved 24.6% year over year to $11.4 billion in the quarter, surpassing the Zacks Consensus Estimate of $10.6 billion.

Better-than-expected performance resulted from strong demand for its construction equipment as well as cost-control efforts. Sales increased across all regions, with largest increase in North America, while China sales remained strong.

The management also raised its revenue and earnings guidance for the year.

Rising Earnings Estimates

Analysts have raised their estimates for the company after excellent earnings. The Zacks Consensus Estimate for the current and the next fiscal year have increased to $6.40 per share and $7.63 per share from $5.26 and $6.74, before the results.

The company has been beating estimates consistently over the past few quarters. The average positive surprise for the past four quarters is 53.1%.

Bear of the Day:

Headquartered in New York City, Avon Products is the world's largest direct seller with more than 6 million active independent sales representatives. Avon products, which are available in over 70 countries, include color cosmetics, skincare, fragrance, fashion and home products, under brand names like Avon Color, ANEW, Skin-So-Soft and Advance Techniques.

Disappointing Results

The company reported weak results for its third quarter. Adjusted earnings from continuing operations came it at 3 cents per share in the third quarter, missing the Zacks Consensus Estimate of 7 cents. This was the fifth straight quarter of miss for the company.

Total revenue was up 1% year over year and also slightly ahead of the Zacks Consensus Estimate. The management expects full-year results to be weaker than the guidance provided earlier.

"With mixed results in Q3 and some positive trends, we expect to see modest improvement continue in Q4. However, it will not be enough to overcome the slow start to 2017, and thus we expect annual results to come in below our 2017 guidance.”

The stock plunged almost 10% following the release and is now down about 66% this year.

Falling Estimates

As a result of worsening outlook for the company, analysts have been cutting their estimates. Zacks Consensus Estimates for the current and the next year are now at a loss of ($0.02) per share and earnings of $0.18 per share, down from $0.09 and $0.27 per share, before the results.

Declining estimates sent AVP back to Zacks Rank # 5. The following chart shows the negative earnings and price momentum for AVP:

Additional content:

3 Stocks Under $10 that Plummeted Wednesday

At Zacks, we suggest that investors pay close attention to our proven stock-picking system, which stresses the importance of earnings estimate revisions in finding winning stocks. But we also understand that lower-priced stocks often make attractive investments, and we will always cover stocks that are making newsworthy moves, big or small.

With that said, stocks that are currently trading under $10 per share can often be particularly enticing to many retail investors, as they present the chance to scoop up large positions akin to what intuitional investors and Wall Street big-wigs do with S&P 500 giants.

However, stocks trading under $10 are subject to substantial swings, which can often happen in one trading session. This means that these $10 or less stocks are some of the biggest movers on any given day.

Now, let’s take a look at three noteworthy companies trading for less than $10 per share that  tumbled today:

JA Solar Holdings Co., Ltd.

This Beijing-based solar energy company has grabbed a lot of attention lately, and its stock price had soared almost 70% this year up to today as renewable energy remains a hot-button issue. But on Tuesday, shares of JA Solar sank by over 14% to $6.85 per share, which is down nearly 20% from their 52-week high.

The manufacturer of high-performance solar cells saw its stock price fall after reporting that gross profits fell 10% year-over-year. The company also missed earnings estimates, and its cell shipments declined by 7.3%. JA Solar is currently a Zacks Rank #3 (Hold).

Mesoblast Limited

Mesoblast, which develops cell-based medicines, saw its stock price tank over 9% today, just one day after posting first-quarter 2018 financial results that failed to inspire investor confidence. Mesoblast Limited is currently a Zacks Rank #5 (Strong Sell) and sports an “F” for both Value and Growth in our Style Scores system.

The biomedicine company’s current P/S ratio is 191.78, which is insanely high even for comparable companies in this tough industry. What’s worse, based on our Zacks Consensus estimates, Mesoblast revenues are projected to fall in the upcoming two quarters. Shares of Mesoblast fell to near their 52-week low, as they rest around $4.90 per share.

21Vianet Group, Inc.

Shares of 21Vianet Group, one of China’s leading carrier-neutral internet data center providers, plummeted almost 5.50% after the company announced today that it would report its third-quarter 2017 financial results on Tuesday, Dec. 5.

Based on our consensus estimates, 21Vianet Group is projected to post a $2.06 per share third-quarter loss. The company almost broke even in the year-ago period. It seems that investors might have started to sell their positions as they get nervous about a potentially massive year-over-year EPS decline. 21Vianet Group is currently a Zacks Rank #3 (Hold) and scored a “D” for both Value and Momentum in our Styles Scores system.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>

Want more stock market analysis from this author? Make sure to follow @Ryan_McQueeney on Twitter!

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>

Zacks Restaurant Recommendations:In addition to dining at these special places, you can feast on their stock shares. A Zacks Special Report spotlights 5 recent IPOs to watch plus 2 stocks that offer immediate promise in a booming sector. Download it free »

About the Bull and Bear of the Day

Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous analyst coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter:  https://twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/performance

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
21Vianet Group, Inc. (VNET) : Free Stock Analysis Report
 
Avon Products, Inc. (AVP) : Free Stock Analysis Report
 
Caterpillar, Inc. (CAT) : Free Stock Analysis Report
 
Mesoblast Limited (MESO) : Free Stock Analysis Report
 
JA Solar Holdings, Co., Ltd. (JASO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research